🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michihisa Kono

Asahikawa Medical College Hospital

ORCID: 0000-0002-8506-928X

Also affiliated with Asahikawa Medical University, Dana-Farber Cancer Institute, Asahikawa University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations”.

The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations

Oral Oncology(2022)10.1016/j.oraloncology.2022.106012

N/A

0DataRank · unranked

43 citations

Shin Saito, Ann Marie Egloff, Clint Allen, Ravindra Uppaluri, Michihisa Kono

Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3477

N/A

0DataRank · unranked

15 citations

Michihisa Kono, Hoang C.B. Nguyen, Ann Marie Egloff, Cameron Messier, Patrick H. Lizotte +4 more

Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer

Oral Oncology(2024)10.1016/j.oraloncology.2024.106795

N/A

0DataRank · unranked

6 citations

Shin Saito, Masahiro Rokugo, Ann Marie Egloff, Ravindra Uppaluri, Michihisa Kono

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy

JCI Insight(2025)10.1172/jci.insight.190924

N/A

0DataRank · unranked

10 citations

Tatsuaki Daimon, Hiroshi Hongo, Sheng-Yu Ku, Hiroki Ozawa, Naoki Haratake +14 more